- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4196 - 1,2,4-Triazoles
Patent holdings for IPC class A61K 31/4196
Total number of patents in this class: 2773
10-year publication summary
|
184
|
218
|
185
|
227
|
254
|
237
|
208
|
183
|
154
|
57
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Synta Pharmaceuticals Corp. | 204 |
80 |
| Axsome Therapeutics, Inc. | 213 |
54 |
| F. Hoffmann-La Roche AG | 7958 |
50 |
| Novartis AG | 11238 |
47 |
| Bayer Pharma AG | 1096 |
37 |
| Boehringer Ingelheim International GmbH | 4629 |
29 |
| Ardea Biosciences, Inc. | 79 |
29 |
| Merck Sharp & Dohme LLC | 3689 |
28 |
| Genentech, Inc. | 3742 |
27 |
| Bristol-myers Squibb Company | 5080 |
26 |
| Gilead Sciences, Inc. | 1879 |
26 |
| Karyopharm Therapeutics Inc. | 121 |
26 |
| Hoffmann-La Roche Inc. | 3060 |
25 |
| Rigel Pharmaceuticals, Inc. | 613 |
25 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
20 |
| Eli Lilly and Company | 3645 |
19 |
| BASF SE | 19740 |
18 |
| The Regents of the University of California | 18943 |
18 |
| Merck Sharp & Dohme Corp. | 2247 |
18 |
| Pfizer Inc. | 3322 |
18 |
| Other owners | 2153 |